Compliance and Efficacy in the Use of PICOPREP®

NCT01220453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2165

Last updated 2012-10-08

No results posted yet for this study

Summary

The present trial is aimed to document efficacy (bowel cleanliness), acceptance and tolerability as well as patient comfort in the use of the new bowel cleansing product PICOPREP® in every day practice. In particular, it should be evaluated, whether bowel cleanliness, acceptance, tolerability and patient comfort are affected by specific practice procedures, changes in dose etc.

Conditions

  • Bowel Cleanliness

Sponsors & Collaborators

  • Ferring Arzneimittel GmbH

    collaborator INDUSTRY
  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-05-31
Completion
2011-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220453 on ClinicalTrials.gov